China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A study on how HNRNPA2B1 affects the sensitivity of advanced prostate cancer to CDK4/6 inhibitor treatment'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129749
Registration Time: 2026/08/10
Type: Observational study
Primary Sponsor: Second Xiangya Hospital of CSU
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331186
Published by HT Digital Content Services with permission from Health Daily Digest....